Invention Grant
- Patent Title: Dihydropyridinone MGAT2 inhibitors
- Patent Title (中): 二氢吡啶酮MGAT2抑制剂
-
Application No.: US14288422Application Date: 2014-05-28
-
Publication No.: US09365558B2Publication Date: 2016-06-14
- Inventor: Saleem Ahmad , Lidet A. Negash
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Barry H. Jacobsen
- Main IPC: C07D211/86
- IPC: C07D211/86 ; C07D401/08 ; C07D401/10 ; C07D417/04 ; C07D211/78 ; A61K31/4412 ; C07D409/04 ; C07D401/04 ; C07D409/14 ; A61K45/06 ; C07D211/90
Abstract:
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Public/Granted literature
- US20140357670A1 DIHYDROPYRIDINONE MGAT2 INHIBITORS Public/Granted day:2014-12-04
Information query
